SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Hypertensive Disorders of Pregnancy and Future Cardiovascular Health.

Melchiorre, K; Thilaganathan, B; Giorgione, V; Ridder, A; Memmo, A; Khalil, A (2020) Hypertensive Disorders of Pregnancy and Future Cardiovascular Health. Front Cardiovasc Med, 7. p. 59. ISSN 2297-055X https://doi.org/10.3389/fcvm.2020.00059
SGUL Authors: Khalil, Asma

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (663kB) | Preview

Abstract

Hypertensive disorders of pregnancy (HDP) occur in almost 10% of gestations. These women are known to have higher cardiovascular morbidity and mortality later in life in comparison with parous controls who had normotensive pregnancies. Several studies have demonstrated that women with preeclampsia present in a state of segmental impaired myocardial function, biventricular chamber dysfunction, adverse biventricular remodeling, and hypertrophy, a compromised hemodynamic state and indirect echocardiographic signs of localized myocardial ischemia and fibrosis. These cardiac functional and geometric changes are known to have strong predictive value for cardiovascular disease in non-pregnant subjects. A "dose effect" response seems to regulate this relationship with severe HDP, early-onset HDP, coexistence of fetal growth disorders, and recurrence of HDP resulting in poorer cardiovascular measures. The mechanism underlying the relationship between HDP in younger women and cardiovascular disease later in life is unclear but could be explained by sharing of pre-pregnancy cardiovascular risk factors or due to a direct impact of HDP on the maternal cardiovascular system conferring a state of increased susceptibility to future metabolic or hemodynamic insults. If so, the prevention of HDP itself would become all the more urgent. Shortly after delivery, women who experienced HDP express an increased risk of classic cardiovascular risk factors such as essential hypertension, renal disease, abnormal lipid profile, and diabetes with higher frequency than controls. Within one or two decades after delivery, this group of women are more likely to experience premature cardiovascular events, such as symptomatic heart failure, myocardial ischemia, and cerebral vascular disease. Although there is general agreement that women who suffered from HDP should undertake early screening for cardiovascular risk factors in order to allow for appropriate prevention, the exact timing and modality of screening has not been standardized yet. Our findings suggest that prevention should start as early as possible after delivery by making the women aware of their increased cardiovascular risk and encouraging weight control, stop smoking, healthy diet, and daily exercise which are well-established and cost-effective prevention strategies.

Item Type: Article
Additional Information: Copyright © 2020 Melchiorre, Thilaganathan, Giorgione, Ridder, Memmo and Khalil. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: cardiovascular disease, coronary artery disease, essential hypertension, gestational hypertension, heart failure, hypertensive disorders of pregnancy, preeclampsia
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Front Cardiovasc Med
ISSN: 2297-055X
Language: eng
Dates:
DateEvent
15 April 2020Published
24 March 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
765274Horizon 2020UNSPECIFIED
PubMed ID: 32351977
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111941
Publisher's version: https://doi.org/10.3389/fcvm.2020.00059

Actions (login required)

Edit Item Edit Item